Goldman Sachs’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,770
| Closed | -$170K | – | 4732 |
|
|
2024
Q1 | $170K | Sell |
9,770
-13,518
| -58% | -$235K | ﹤0.01% | 4369 |
|
|
2023
Q4 | $299K | Sell |
23,288
-141,688
| -86% | -$1.82M | ﹤0.01% | 4188 |
|
|
2023
Q3 | $6.1M | Sell |
164,976
-17,504
| -10% | -$648K | ﹤0.01% | 2335 |
|
|
2023
Q2 | $7.34M | Sell |
182,480
-84,388
| -32% | -$3.4M | ﹤0.01% | 2283 |
|
|
2023
Q1 | $19.3M | Buy |
266,868
+17,123
| +7% | +$1.24M | ﹤0.01% | 1546 |
|
|
2022
Q4 | $20.5M | Buy |
249,745
+59,398
| +31% | +$4.87M | 0.01% | 1599 |
|
|
2022
Q3 | $18M | Buy |
190,347
+72,815
| +62% | +$6.88M | ﹤0.01% | 1683 |
|
|
2022
Q2 | $22.9M | Sell |
117,532
-27,992
| -19% | -$5.45M | 0.01% | 1524 |
|
|
2022
Q1 | $33.8M | Buy |
145,524
+42,943
| +42% | +$9.97M | 0.01% | 1371 |
|
|
2021
Q4 | $40.4M | Sell |
102,581
-12,390
| -11% | -$4.88M | 0.01% | 1277 |
|
|
2021
Q3 | $51.5M | Buy |
114,971
+11,063
| +11% | +$4.95M | 0.01% | 1078 |
|
|
2021
Q2 | $40.4M | Buy |
103,908
+19,039
| +22% | +$7.4M | 0.01% | 1230 |
|
|
2021
Q1 | $30.5M | Sell |
84,869
-20,990
| -20% | -$7.54M | 0.01% | 1376 |
|
|
2020
Q4 | $52M | Sell |
105,859
-20,750
| -16% | -$10.2M | 0.01% | 937 |
|
|
2020
Q3 | $41M | Sell |
126,609
-14,460
| -10% | -$4.69M | 0.01% | 984 |
|
|
2020
Q2 | $51.4M | Buy |
141,069
+115,763
| +457% | +$42.2M | 0.02% | 841 |
|
|
2020
Q1 | $5.38M | Buy |
25,306
+8,405
| +50% | +$1.79M | ﹤0.01% | 2196 |
|
|
2019
Q4 | $6.96M | Buy |
16,901
+823
| +5% | +$339K | ﹤0.01% | 2236 |
|
|
2019
Q3 | $5.68M | Buy |
16,078
+4,702
| +41% | +$1.66M | ﹤0.01% | 2241 |
|
|
2019
Q2 | $5.72M | Buy |
11,376
+1,002
| +10% | +$504K | ﹤0.01% | 2234 |
|
|
2019
Q1 | $10.3M | Sell |
10,374
-2,578
| -20% | -$2.56M | ﹤0.01% | 1994 |
|
|
2018
Q4 | $11.2M | Sell |
12,952
-3,463
| -21% | -$3.01M | ﹤0.01% | 1872 |
|
|
2018
Q3 | $17M | Sell |
16,415
-469
| -3% | -$485K | ﹤0.01% | 1744 |
|
|
2018
Q2 | $15.5M | Buy |
16,884
+9,956
| +144% | +$9.15M | ﹤0.01% | 1776 |
|
|
2018
Q1 | $6.76M | Buy |
6,928
+6,117
| +754% | +$5.96M | ﹤0.01% | 2162 |
|
|
2017
Q4 | $367K | Buy |
811
+13
| +2% | +$5.88K | ﹤0.01% | 3576 |
|
|
2017
Q3 | $330K | Buy |
798
+215
| +37% | +$88.9K | ﹤0.01% | 3681 |
|
|
2017
Q2 | $204K | Sell |
583
-7,466
| -93% | -$2.61M | ﹤0.01% | 3975 |
|
|
2017
Q1 | $4.14M | Buy |
8,049
+6,928
| +618% | +$3.56M | ﹤0.01% | 2307 |
|
|
2016
Q4 | $398K | Sell |
1,121
-143
| -11% | -$50.8K | ﹤0.01% | 3579 |
|
|
2016
Q3 | $676K | Buy |
1,264
+620
| +96% | +$332K | ﹤0.01% | 3266 |
|
|
2016
Q2 | $363K | Buy |
+644
| New | +$363K | ﹤0.01% | 3528 |
|
|
2015
Q4 | – | Sell |
-1,136
| Closed | -$893K | – | 4463 |
|
|
2015
Q3 | $893K | Buy |
+1,136
| New | +$893K | ﹤0.01% | 2970 |
|
|
2015
Q1 | – | Sell |
-2,100
| Closed | -$1.41M | – | 4478 |
|
|
2014
Q4 | $1.41M | Buy |
+2,100
| New | +$1.41M | ﹤0.01% | 2722 |
|